Self assembled skin substitute (SASS): All patients in Phase B will receive Self assembled skin substitute (SASS)
Study summary
This clinical trial is designed to assess the safety, effectiveness and benefits of Self Assembled Skin Substitute SASS grafts as a permanent skin replacement for the treatment of full-thickness burn wounds that require permanent coverage where the availability of donor sites is limited.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Deep second degree burns or third degree burns over 50% TBSA (Total body surface area) at time of recruitment or as determined by the surgeon;
* Limited availability of donor sites for autografts;
* Consent obtained by the participant or by the appropriate representative in case of inapt prospective participants or minors.
Exclusion Criteria:
* Skin grafting needed only on the face, hands, feet, ears or genital area;
* Connective tissue diseases;
* Hypersensitivity to bovine proteins;
* Coagulation disorders prior being burned;
* Immunodeficiency prior being burned;
* Uncontrolled diabetes prior being burned;
* Permanent wound coverage before SASS grafts are ready;
Primary outcome measure(s)
Percentage of graft take site A vs site B (Phase A 17 patients) — < 1 month Clinical assessment; Image analysis
Percentage of graft take of all SASS (Phase A+B) — < 1 month Clinical assessment
Percentage of graft take according to sites (Phase A+B) — < 1 month Clinical assessment
Trial sites (8)
Facility
City
Region
Status
Foothill Medcial Centre
Calgary
Alberta
Recruiting
Mackenzie Health Science's Centre
Edmonton
Alberta
Recruiting
Vancouver General Hospital
Vancouver
British Columbia
Recruiting
BC Children's Hospital Plastic Surgery Clinic
Vancouver
British Columbia
Recruiting
Winnipeg Health Science Center
Winnipeg
Manitoba
Recruiting
Hospital for Sick Children (Sickkids)
Toronto
Ontario
Recruiting
Hôpital Sainte Justine
Montreal
Quebec
Recruiting
CHU de Québec - Unité des grands brûlés
Québec
Quebec
Recruiting
More CHU de Quebec-Universite Laval trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.